41 / 48
Jenkins RW, et al. BJC 2018
Improved understanding of
molecular and immunologic
mechanisms of ICI response
and resistance may not only
identify novel predictive
and/or prognostic
biomarkers, but also
ultimately guide optimal
combination/sequencing of ICI
therapy in the clinic.